Nephron Recalls Fentanyl and Bupivacaine Injection Due to Glass Contamination
Nephron Pharmaceuticals is recalling 1,370 bags of Fentanyl Citrate and Bupivacaine HCl injection due to potential glass contamination.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves potential glass contamination in an injectable medication, which poses a significant risk of injury.
Plain-English summary
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center is recalling 1,370 bags of PF-Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL. The recall is being conducted due to Good Manufacturing Practice (GMP) deviations that resulted in potential glass contamination.
The affected product is identified by NDC 69374-530-25. The specific lots involved are FB9014A with an expiration date of 12/09/2019 and FB9017A with an expiration date of 12/16/2019. The product was distributed nationwide.
Healthcare providers and patients should discontinue use of the affected lots and contact the manufacturer or their supplier for further instructions. This recall is classified as Class II by the FDA.
The recalled product
- Product
- PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only Total Dose: (500 mcg/312.5 mg)/250 mL, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-530-25
- Category
- Drug — Injectable Medication
- Hazard
- Affected units
- 1,370
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: FB9014A Exp. 12/09/2019
- FB9017A Exp. 12/16/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
See all →- LowNephron Recalls Succinylcholine Chloride Injection Due to Incorrect Labeling
FDA (Drugs) · 2019-11-06
- SevereNephron Recalls Fentanyl and Ropivacaine Injection Due to Glass Contamination
FDA (Drugs) · 2019-10-30
- SevereNephron Recalls Fentanyl and Bupivacaine Injection Due to Glass Contamination
FDA (Drugs) · 2019-10-30
- SevereNephron Amino Acid Injection Recalled for Sterility and Leak Concerns
FDA (Drugs) · 2019-10-30
- SevereNephron Recalls del Nido Cardioplegia Solution Due to Sterility Concerns
FDA (Drugs) · 2019-10-30
Same hazard · glass contamination
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Tangerine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Acetylcysteine Solution Due to Particulate Matter
FDA (Drugs) · 2026-08-26